We are live on
!
Find out more
VCM
Violich Capital Management Portfolio holdings
AUM
$919M
1-Year Est. Return
40.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.25%
1 Year Est. Return
+40.7%
3 Year Est. Return
+100.28%
5 Year Est. Return
+135.3%
10 Year Est. Return
+480.06%
AUM
$279M
AUM Growth
+$22.4M
(+8.7%)
Cap. Flow
+$2.98M
Cap. Flow
% of AUM
1.07%
Top 10 Holdings %
Top 10 Hldgs %
49.23%
Holding
111
New
3
Increased
37
Reduced
50
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$3.8M |
| 2 |
Qualcomm
QCOM
|
+$2.74M |
| 3 |
Danaher
DHR
|
+$712K |
| 4 |
Walt Disney
DIS
|
+$630K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$1.52M |
| 2 |
Accenture
ACN
|
+$818K |
| 3 |
Newmont
NEM
|
+$737K |
| 4 |
SPDR Gold Trust
GLD
|
+$609K |
| 5 |
Annaly Capital Management
NLY
|
+$551K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.2% |
| 2 | Energy | 12.91% |
| 3 | Healthcare | 12.78% |
| 4 | Financials | 9.62% |
| 5 | Communication Services | 8.67% |
Similar funds
AIA
FFL
TCM
SC
KI
BDF
GFG
OWIM
Violich Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Violich Capital Management held 111 positions worth $279M, up 8.7% from $256M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Violich Capital Management's Q4 2013 filing shows 3 new, 37 increased, 50 reduced and 9 closed positions. Its largest new stake was Danaher: 14,477 shares worth $751K. The largest sale was Teva Pharmaceuticals, an estimated $1.52M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Energy and Healthcare.
- Violich Capital Management's largest Q4 2013 buy was Danaher: 14,477 shares worth $751K.
- Violich Capital Management added most to Aetna Inc in Q4 2013, an estimated $3.8M increase.
- Violich Capital Management's biggest Q4 2013 reduction was Accenture, cutting an estimated $818K.
- Violich Capital Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $1.52M.
- Violich Capital Management's ten largest holdings make up 49% of its $279M portfolio in Q4 2013.
- Violich Capital Management opened 3 new positions and closed 9 in Q4 2013.
- Violich Capital Management's portfolio value rose 8.7% quarter-over-quarter to $279M.
Based on Violich Capital Management's 13F filing for Q4 2013, filed 18 Feb 2014.